These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 9252662)

  • 41. A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo.
    Mata JE; Joshi SS; Palen B; Pirruccello SJ; Jackson JD; Elias N; Page TJ; Medlin KL; Iversen PL
    Toxicol Appl Pharmacol; 1997 May; 144(1):189-97. PubMed ID: 9169084
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm.
    Wuonola MA; Palfreyman MG; Motohashi N; Kawase M; Gabay S; Gupta RR; Molnár J
    Anticancer Res; 1998; 18(1A):337-48. PubMed ID: 9568100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.
    Rha SY; Izbicka E; Lawrence R; Davidson K; Sun D; Moyer MP; Roodman GD; Hurley L; Von Hoff D
    Clin Cancer Res; 2000 Mar; 6(3):987-93. PubMed ID: 10741725
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory effect of telomere-mimic phosphorothioate oligodeoxy nucleotides (S-ODNS) on human tumor cell lines.
    Saeki T; Takashima S; Tachibana M; Koga M; Hiyama E; Salomon DS; Holland JF; Ohnuma T
    Oncology; 1999 Oct; 57 Suppl 2():27-36. PubMed ID: 10545800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibitory effects of telomere-mimic phosphorothioate oligonucleotides on various human tumor cells in vitro.
    Ohnuma T; Li FL; Holland JF
    Anticancer Res; 1997; 17(4A):2455-8. PubMed ID: 9252662
    [TBL] [Abstract][Full Text] [Related]  

  • 46.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 47.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 48.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.